跳至主要内容
临床试验/NCT04514666
NCT04514666Unknown不适用

Exhaled Volatile Organic Compounds as Potential Predictive Biomarkers of Chronic Kidney and Liver Rejection After Transplants

Societa Italiana di Chirurgia ColoRettale1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2021年10月2日最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
入组人数
100
试验地点
1
主要终点
Volatile organic compounds after liver transplant

研究概览

简要总结

Kidney and liver trasplants represent very challenging lifesaving and effective surgical procedures for patients with end-stage kidney and/or liver disease.

Chronic rejection may occur in 3 to 17% livers transplants and in 20 to 40% kidney transplants.

While acute rejection is clearly detected due to the clinical features and laboratory tools, the early identification of chronic rejection is still challenging since the clinical features are often silents and laboratory tests become suggestive when the damage due to the rejection is almost irreversible.

Considering the recent application of the breathomic to liver and kidney disease and the difficulty in the early detection of chronic rejection after liver and kidney transplants, the analysis of the exhaled VOCs pattern could help early detection of chronic rejection allowing a prompt medical treatment.

详细描述

Kidney and liver trasplants represent very challenging lifesaving and effective surgical procedures for patients with end-stage kidney and/or liver disease.

Nowadays the short and long term success rate of kidney and liver trasplants is pretty hight. Nevertheless, transplant rejection remains one of the biggest limitations with a strong impact on patients survival.

Usually acute rejection occurs within 3 months after the transplant and is the most common cause of transplant failure and the most common indication for re-transplantation .

Chronic rejection may occur in 3 to 17% livers transplants and in 20 to 40% kidney transplants.

While acute rejection is clearly detected due to the clinical features and laboratory tools, the early identification of chronic rejection is still challenging since the clinical features are often silents and laboratory tests become suggestive when the damage due to the rejection is almost irreversible.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patients eligible for liver or kidney transplant
  • •Written informed consent

排除标准

  • •Acute liver failure
  • •Acute liver and kidney rejection
  • •Re-transplant
  • •Pregnancy
  • •Any psychiatric disease

研究组 & 干预措施

Liver/kidney transplant

Experimental

The breath of patients undergoing liver or kidney transplant will be sampled and analysed

干预措施: Breath analysis (Other)

结局指标

主要结局

Volatile organic compounds after liver transplant

时间窗: 1 year

to evaluate the pattern of volatile organic compounds able to identify the onset of chronic failure/rejection after liver transplants

Volatile organic compounds in end stage liver disease

时间窗: 30 days

to evaluate the pattern of volatile organic compounds in patients elegible for liver transplant

Volatile organic compounds in end stage kidney disease

时间窗: 30 days

to evaluate the pattern of volatile organic compounds in patients elegible for kidney transplant

次要结局

未报告次要终点

研究者

发起方
Societa Italiana di Chirurgia ColoRettale
申办方类型
Network
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验